Shuttle Pharmaceuticals Changes Certifying Accountant (Form 8-K)
Shuttle Pharmaceuticals Holdings, Inc. (SEC file no. 0001757499) filed an 8-K on November 6, 2026 at 22:25 reporting a change in its certifying accountant (Item 4.01). Such changes often signal audit opinion concerns, internal control remediation, or preparation for IPO by upgrading to a PCAOB-registered firm.
51CFO view：CFOs must complete new auditor onboarding within 6 months, restart SOX 404(a) testing baselines, and—if prior audit opinions were qualified—disclose remediation status and third-party validation in S-1. PCAOB registration of the new firm is non-negotiable for IPO eligibility.
Shuttle Pharmaceuticals Holdings, Inc. (SEC file no. 0001757499) filed an 8-K on November 6, 2026 at 22:25 reporting a change in its certifying accountant (Item 4.01). Such changes often signal audit opinion concerns, internal control remediation, or preparation for IPO by upgrading to a PCAOB-registered firm.
Source：SEC EDGAR · 8-K 重大事项公告
Why this matters to your CFO search
Where this touches your finance hire
Every listing event changes what you need from a CFO. Start from the step you are actually at.
Who owns SEC reporting and US GAAP?
Signature responsibility for 10-K / 10-Q / 8-K / 20-F, and common comments.
Read →
Who builds SOX 404 internal controls?
The first-year audit requirement after listing, and when to start.
Read →
What to do 18 months before filing
Financial readiness: audit basis, internal control, equity restatement.
Read →